Abstract:Background: Tertiary lymphoid structures (TLS) have an effect on hepatocellular carcinoma (HCC), but the underlying mechanism remains to be elucidated. Methods: Intratumoral TLS (iTLS) was classified in the Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA-LIHC) cohort using pathological sections from the Cancer Digital Slide Archive. Univariate and multivariate Cox regression analyses were performed to validate the effect of iTLS on overall survival (OS), relapse-free survival (RFS), and disease-free survival (DFS). The genes differentially expressed between the iTLS-negative and iTLS-positive groups were analyzed in combination with sequencing data. Gene set enrichment analysis (GSEA) was used to explore the signaling pathways affected by these differentially expressed genes. The random forest algorithm was used to identify genes with the highest correlation with the iTLS in the training set. Multivariate logistic regression was used to build a model to predict iTLS in tissue samples. Spearman's correlation was used to analyze the relationship between TLS-associated chemokines and signature genes, and CIBERSORT was used to calculate immune infiltration scores. Copy number variation and its relationship with immune cell infiltration and signature genes were assessed using the gene set cancer analysis (GSCA). The Correlation R package was used for gene ontology (GO), disease ontology (DO), and gene mutation analyses. The GSCA was used for drug sensitivity analysis. LASSO regression was used to build prognostic models, and external data were used to validate the models. Results: There were 218 positive and 146 negative samples for iTLS. iTLS was significantly associated with better RFS and DFS according to Cox regression analysis. Twenty signature genes that were highly associated with iTLS positivity were identified. GO and mutation analyses revealed that the signature genes were associated with immunity. Most signature genes were sensitive to immune checkpoint inhibitors. Risk scores calculated using a characteristic gene-based prognostic model were found to be an independent prognostic factor for OS. Conclusions: The improvement of RFS in HCC by iTLS was not limited to the early period as previously reported. iTLS improved DFS in patients. Characteristic genes are closely related to the formation of iTLS and TLS chemokines in HCC. These genes are closely related to immunity in terms of cellular infiltration, biological functions, and signaling pathways. Most are sensitive to immune checkpoint inhibitors, and their expression levels can affect prognosis.

IgA- Tertiary Lymphoid Structures Correlates With a Better Prognosis in GADC Patients

The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma

CD8+ T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer

The High Level of Tertiary Lymphoid Structure Is Correlated With Superior Survival in Patients With Advanced Gastric Cancer

Tertiary Lymphoid Structure Patterns Predicted Anti-Pd1 Therapeutic Responses in Gastric Cancer.

Abstract 7466: Exploring tertiary lymphoid structures and immune cell interactions in gastric cancer prognosis

Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer

Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies

Immune Microenvironment Spatial Landscapes of Tertiary Lymphoid Structures in Gastric Cancer

Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors

Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma

Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+CD103+CD8+Trm Cell Response to PD-1 Blockade in Gastric Cancer

Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma

Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer

Tertiary lymphoid structures' pattern and prognostic value in primary adenocarcinoma of jejunum and ileum

Tertiary Lymphoid Structure-Associated B Cells Enhance Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy

The relationship between the tertiary lymphoid structure and immune-infiltrating cells in gastrointestinal cancers: A systematic review and meta-analysis

Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective

Tumor-associated Tertiary Lymphoid Structure Predicts Postoperative Outcomes in Patients with Primary Gastrointestinal Stromal Tumors.

Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer